Department of Biochemistry, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India.
Med Microbiol Immunol. 2009 Nov;198(4):247-56. doi: 10.1007/s00430-009-0124-7. Epub 2009 Sep 25.
Capsular F1 and secretory V antigen are the putative vaccine candidates for plague, caused by Yersinia pestis. Contemplating this, we studied the immunogenicity and protective efficacy of collinearly synthesized B- and T-cell epitopes (B-T constructs) of V antigen entrapped in poly (DL-lactide-co-glycolide) microparticles immunized intranasally using single dose immunization schedule in outbred, H-2(b) and H-2(d) mice. High antibody levels were observed in terms of IgG, IgA and SIgA peak titers in sera and mucosal washes to different B-T constructs. The constructs ai, bi and fi especially showed high peak antibody titers ranging from 51,200 to 204,000, which were maintained till day 120 post immunization. IgG/IgA Specific activity in sera and washes correlated well with the peak antibody titers. Moreover, all the B-T constructs showed mixed IgG1 and IgG2a/2b response, variable immunoreactivity as well as memory response with V antigen. B-T constructs, viz ai, ak, bi, fi, di and ik showed comparatively high isotype levels. These constructs showed high immunoreactivity, and good recall response with V antigen. Finally, in vivo protective study in BALB/c mice demonstrated the protective efficacy of three B-T constructs (ai, bi and fi) against lethal doses of Yersinia pestis till day 20 post challenge, while construct 'id' showed partial protection.
荚膜 F1 和分泌 V 抗原是鼠疫的潜在疫苗候选物,由鼠疫耶尔森菌引起。考虑到这一点,我们研究了 V 抗原的共线性合成 B 细胞和 T 细胞表位(B-T 构建体)在聚(DL-丙交酯-co-乙交酯)微球中的免疫原性和保护效力,这些微球通过单次免疫方案鼻内免疫,用于近交系、H-2(b)和 H-2(d)小鼠。在血清和粘膜冲洗液中,观察到针对不同 B-T 构建体的 IgG、IgA 和 SIgA 峰值滴度的高抗体水平。构建体 ai、bi 和 fi 特别显示出高的峰值抗体滴度,范围从 51,200 到 204,000,这些抗体滴度一直维持到免疫后 120 天。血清和冲洗液中的 IgG/IgA 特异性活性与峰值抗体滴度相关良好。此外,所有 B-T 构建体均显示出混合 IgG1 和 IgG2a/2b 反应、可变免疫反应以及与 V 抗原的记忆反应。B-T 构建体,即 ai、ak、bi、fi、di 和 ik 显示出相对较高的同种型水平。这些构建体显示出高免疫反应性和与 V 抗原的良好回忆反应。最后,在 BALB/c 小鼠中的体内保护研究表明,三种 B-T 构建体(ai、bi 和 fi)对鼠疫耶尔森菌的致死剂量具有保护效力,直至挑战后 20 天,而构建体“id”则显示出部分保护。